ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.

September 15, 2006

Also In sudden policy change, NIH proposes one-year ban on consulting by employees.

October 1, 2004

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007

NCI Toughens Criteria for MERIT Awards

February 23, 1996